ClinicalTrials.gg
Drug

Abiraterone Acetate clinical trials

Also written Zytiga, CB7630, Yonsa and JNJ-212082.

A product of Abiraterone; its studies count on that page too.

studies test it
127
open now
15
in phase 3
13
first study started
2005

Counted the way a researcher would: Abiraterone Acetate with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Abiraterone Acetate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Abiraterone Acetate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Apr 2011 · ZYTIGA · NDA 202379 (FDA, Drugs@FDA)
European Union
5 Sept 2011 · Zytiga · EMEA/H/C/002321 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Abiraterone Acetate
98
Zytiga® (Abiraterone Acetate)
2
Treatment A: abiraterone acetate
2
Treatment B: abiraterone acetate
2
Treatment C: abiraterone acetate
2

Brand

Zytiga
53
Yonsa
11

Development codes

CB7630
18
JNJ-212082
6
BR9004
3
BR9004-1
3
JNJ21208
1

Studies by the year they started

127 studies that test it; most in 2020 (13)

Studies that test Abiraterone Acetate, by start year
YearStudies
20051
20062
20074
20082
20095
20104
20118
201211
201312
201411
20155
20167
20178
20184
20197
202013
20218
20224
20232
20245
20253
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
37
Phase 2
79
Phase 3
13
Phase 4
4
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 49 · Other 78

Janssen Research & Development, LLC (21) · Cougar Biotechnology, Inc. (9) · M.D. Anderson Cancer Center (6) · University of Washington (4) · Dana-Farber Cancer Institute (3) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) · Sun Pharmaceutical Industries Limited (3) · Mayo Clinic (2)

Often tested with

Tested in the same studies.

Prednisone (27) · Apalutamide (13) · Enzalutamide (13) · Niraparib (6) · Prednisolone (5) · Leuprolide (4) · Cabazitaxel (4) · Docetaxel (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 4 phase 3 studies under way

Abiraterone Acetate is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 8, 1 in phase 3

Studies that test Abiraterone Acetate, phase 3 first.

Studies

Open first, then newest update. How each study uses Abiraterone Acetate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 127

See all 127 studies that test Abiraterone Acetate →

Given beside what is tested · 60 — Abiraterone Acetate is usual care or a partner of the new treatment

Showing 20 of 60.

As the comparator · 12 — what is tested is compared with Abiraterone Acetate

Codes

What other systems call Abiraterone Acetate · ClinicalTrials.gg INT006603

  • MeSH (NLM) D000069501Abiraterone AcetateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) EM5OCB9YJ6ABIRATERONE ACETATEConfirmed FDA, NLM, Wikidata
  • RxNorm 1100071Confirmed FDA, Wikidata
  • Wikidata Q27888393abiraterone acetateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C68845Abiraterone AcetateOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.